CENTERSPACE (CSR)

US15202L1070 - REIT

67.97  -0.99 (-1.44%)

Fundamental Rating

3

Taking everything into account, CSR scores 3 out of 10 in our fundamental rating. CSR was compared to 21 industry peers in the Residential REITs industry. While CSR is still in line with the averages on profitability rating, there are concerns on its financial health. CSR is valied quite expensively at the moment, while it does show a decent growth rate.



5

1. Profitability

1.1 Basic Checks

In the past year CSR was profitable.
In the past year CSR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CSR reported negative net income in multiple years.
In the past 5 years CSR always reported a positive cash flow from operatings.

1.2 Ratios

CSR's Return On Assets of 3.99% is fine compared to the rest of the industry. CSR outperforms 71.43% of its industry peers.
CSR has a better Return On Equity (10.58%) than 85.71% of its industry peers.
With a Return On Invested Capital value of 1.30%, CSR is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
CSR had an Average Return On Invested Capital over the past 3 years of 0.64%. This is in line with the industry average of 2.53%.
The last Return On Invested Capital (1.30%) for CSR is above the 3 year average (0.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.99%
ROE 10.58%
ROIC 1.3%
ROA(3y)0.16%
ROA(5y)1.1%
ROE(3y)0.41%
ROE(5y)2.45%
ROIC(3y)0.64%
ROIC(5y)0.64%

1.3 Margins

The Profit Margin of CSR (23.35%) is better than 71.43% of its industry peers.
In the last couple of years the Profit Margin of CSR has declined.
CSR has a Operating Margin of 9.31%. This is in the lower half of the industry: CSR underperforms 76.19% of its industry peers.
CSR's Operating Margin has improved in the last couple of years.
CSR's Gross Margin of 56.42% is in line compared to the rest of the industry. CSR outperforms 42.86% of its industry peers.
In the last couple of years the Gross Margin of CSR has remained more or less at the same level.
Industry RankSector Rank
OM 9.31%
PM (TTM) 23.35%
GM 56.42%
OM growth 3Y23.96%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-26.35%
GM growth 3Y0.91%
GM growth 5Y1.24%

1

2. Health

2.1 Basic Checks

CSR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CSR has been reduced compared to 1 year ago.
CSR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CSR has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that CSR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.30, CSR is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
CSR has a Debt/Equity ratio of 1.26. This is a high value indicating a heavy dependency on external financing.
CSR has a Debt to Equity ratio of 1.26. This is comparable to the rest of the industry: CSR outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACC0.2
WACC6.4%

2.3 Liquidity

A Current Ratio of 0.14 indicates that CSR may have some problems paying its short term obligations.
CSR has a Current ratio of 0.14. This is amonst the worse of the industry: CSR underperforms 80.95% of its industry peers.
CSR has a Quick Ratio of 0.14. This is a bad value and indicates that CSR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.14, CSR is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14

5

3. Growth

3.1 Past

CSR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 303.68%, which is quite impressive.
Measured over the past years, CSR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -25.27% on average per year.
The Revenue has grown by 28.24% in the past year. This is a very strong growth!
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)303.68%
EPS 3YN/A
EPS 5Y-25.27%
EPS growth Q2Q-54.17%
Revenue 1Y (TTM)28.24%
Revenue growth 3Y13.65%
Revenue growth 5Y9.02%
Revenue growth Q2Q-5.57%

3.2 Future

Based on estimates for the next years, CSR will show a very negative growth in Earnings Per Share. The EPS will decrease by -27.05% on average per year.
CSR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.83% yearly.
EPS Next Y-141.38%
EPS Next 2Y-51.98%
EPS Next 3Y-27.05%
EPS Next 5YN/A
Revenue Next Year0.68%
Revenue Next 2Y2.37%
Revenue Next 3Y2.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.54, CSR is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of CSR indicates a rather cheap valuation: CSR is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.06. CSR is around the same levels.
The Forward Price/Earnings Ratio is negative for CSR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 24.54
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.45

4.3 Compensation for Growth

A cheap valuation may be justified as CSR's earnings are expected to decrease with -27.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.98%
EPS Next 3Y-27.05%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.36%, CSR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.46, CSR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, CSR pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.36%

5.2 History

The dividend of CSR decreases each year by -0.79%.
CSR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-0.79%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CSR pays out 66.11% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of CSR has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP66.11%
EPS Next 2Y-51.98%
EPS Next 3Y-27.05%

CENTERSPACE

NYSE:CSR (5/3/2024, 10:40:55 AM)

67.97

-0.99 (-1.44%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.01B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 4.36%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 24.54
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 10.58%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.31%
PM (TTM) 23.35%
GM 56.42%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)303.68%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-141.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.24%
Revenue growth 3Y13.65%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y